Media stories about Aceto (NASDAQ:ACET) have trended somewhat negative on Wednesday, according to Accern. The research group identifies positive and negative media coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Aceto earned a coverage optimism score of -0.07 on Accern’s scale. Accern also gave media headlines about the company an impact score of 43.2847437346016 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.
These are some of the news stories that may have effected Accern Sentiment’s analysis:
Aceto traded up $0.08, reaching $2.98, during mid-day trading on Wednesday, Marketbeat.com reports. 400,500 shares of the company were exchanged, compared to its average volume of 665,394. The company has a quick ratio of 0.80, a current ratio of 1.12 and a debt-to-equity ratio of 0.63. The firm has a market cap of $86.21 million, a P/E ratio of 2.50, a P/E/G ratio of 0.27 and a beta of 1.70. Aceto has a 12-month low of $2.22 and a 12-month high of $17.10.
Aceto (NASDAQ:ACET) last posted its earnings results on Thursday, May 3rd. The company reported $0.01 earnings per share for the quarter, missing analysts’ consensus estimates of $0.23 by ($0.22). The company had revenue of $186.00 million for the quarter. Aceto had a positive return on equity of 7.93% and a negative net margin of 28.23%. During the same period in the prior year, the company posted $0.39 EPS. equities analysts expect that Aceto will post 1.02 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Friday, June 22nd. Shareholders of record on Friday, June 8th will be issued a dividend of $0.01 per share. The ex-dividend date is Thursday, June 7th. This represents a $0.04 dividend on an annualized basis and a yield of 1.34%. Aceto’s dividend payout ratio is currently 21.85%.
ACET has been the subject of a number of analyst reports. Canaccord Genuity restated a “sell” rating and set a $2.00 target price on shares of Aceto in a report on Thursday, May 10th. Craig Hallum lowered Aceto from a “hold” rating to a “sell” rating in a report on Thursday, April 19th. Zacks Investment Research lowered Aceto from a “hold” rating to a “strong sell” rating in a report on Tuesday, February 6th. Finally, ValuEngine lowered Aceto from a “buy” rating to a “hold” rating in a report on Friday, February 2nd. Four analysts have rated the stock with a sell rating and one has issued a hold rating to the company’s stock. Aceto presently has a consensus rating of “Sell” and a consensus price target of $2.00.
Aceto Corporation, together with its subsidiaries, sources, markets, sells, and distributes finished dosage form generics, nutraceutical products, pharmaceutical intermediates and active ingredients, agricultural protection products, and specialty chemicals. The company operates in three segments: Human Health, Pharmaceutical Ingredients, and Performance Chemicals.
Receive News & Ratings for Aceto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aceto and related companies with MarketBeat.com's FREE daily email newsletter.